17355998

Source:http://linkedlifedata.com/resource/pubmed/id/17355998

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012634, umls-concept:C0796392, umls-concept:C1299003
pubmed:issue	4
pubmed:dateCreated	2007-4-17
pubmed:abstractText	To review the efficacy and safety of off-label use of bevacizumab for neovascular ocular diseases.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9203131
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1542-6270
pubmed:author	pubmed-author:ChengChristine MCM, pubmed-author:LynchShalini SSS
pubmed:issnType	Electronic
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	614-25
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:17355998-Angiogenesis Inhibitors, pubmed-meshheading:17355998-Antibodies, Monoclonal, pubmed-meshheading:17355998-Antibodies, Monoclonal, Humanized, pubmed-meshheading:17355998-Clinical Trials as Topic, pubmed-meshheading:17355998-Diabetic Retinopathy, pubmed-meshheading:17355998-Humans, pubmed-meshheading:17355998-Macular Degeneration, pubmed-meshheading:17355998-Vascular Endothelial Growth Factor A
pubmed:year	2007
pubmed:articleTitle	Bevacizumab for neovascular ocular diseases.
pubmed:affiliation	Department of Clinical Pharmacy, University of California, San Francisco, CA 94143, USA. lynchs@pharmacy.ucsf.edu
pubmed:publicationType	Journal Article, Review